Recent studies using NSCLC cell lines and fresh lung tumour tissues suggest CD133 as the lung CSC marker of choice [7], [24], [25], [26] while cytometric analysis and sorting of marker-positive cells is currently the standard method used [27]. Here, PROM1 is linked to non-small cell lung carcinoma.